125 related articles for article (PubMed ID: 21334230)
1. Assessment of oxidative stress in patients with sickle cell disease: The glutathione system and the oxidant-antioxidant status.
Gizi A; Papassotiriou I; Apostolakou F; Lazaropoulou C; Papastamataki M; Kanavaki I; Kalotychou V; Goussetis E; Kattamis A; Rombos I; Kanavakis E
Blood Cells Mol Dis; 2011 Mar; 46(3):220-5. PubMed ID: 21334230
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte and plasma oxidative stress appears to be compensated in patients with sickle cell disease during a period of relative health, despite the presence of known oxidative agents.
Detterich JA; Liu H; Suriany S; Kato RM; Chalacheva P; Tedla B; Shah PM; Khoo MC; Wood JC; Coates TD; Milne GL; Oh JY; Patel RP; Forman HJ
Free Radic Biol Med; 2019 Sep; 141():408-415. PubMed ID: 31279092
[TBL] [Abstract][Full Text] [Related]
3. Impacts of oxidative stress and anti-oxidants on the development, pathogenesis, and therapy of sickle cell disease: A comprehensive review.
Pavitra E; Acharya RK; Gupta VK; Verma HK; Kang H; Lee JH; Sahu T; Bhaskar L; Raju GSR; Huh YS
Biomed Pharmacother; 2024 Jul; 176():116849. PubMed ID: 38823275
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Oxidative Stress Levels and Antioxidant Enzyme Activities in Burst Fractures.
Kuyumcu F; Aycan A
Med Sci Monit; 2018 Jan; 24():225-234. PubMed ID: 29324724
[TBL] [Abstract][Full Text] [Related]
5. Effects of electromagnetic fields exposure on the antioxidant defense system.
Kıvrak EG; Yurt KK; Kaplan AA; Alkan I; Altun G
J Microsc Ultrastruct; 2017; 5(4):167-176. PubMed ID: 30023251
[TBL] [Abstract][Full Text] [Related]
6. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease.
Klings ES; Farber HW
Respir Res; 2001; 2(5):280-5. PubMed ID: 11686897
[TBL] [Abstract][Full Text] [Related]
7. The association of transfusion status with antioxidant enzymes and malondialdehyde level in Nigerians with sickle cell disease.
Abiodun EM; Aisha KG
Asian J Transfus Sci; 2014 Jan; 8(1):47-50. PubMed ID: 24678175
[TBL] [Abstract][Full Text] [Related]
8. Fast Antioxidation Kinetics of Glutathione Intracellularly Monitored by a Dual-Wire Nanosensor.
Jiao YT; Kang YR; Wen MY; Wu HQ; Zhang XW; Huang WH
Angew Chem Int Ed Engl; 2023 Dec; 62(51):e202313612. PubMed ID: 37909054
[TBL] [Abstract][Full Text] [Related]
9. Role of reactive oxygen species and antioxidants in atopic dermatitis.
Sivaranjani N; Rao SV; Rajeev G
J Clin Diagn Res; 2013 Dec; 7(12):2683-5. PubMed ID: 24551611
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species and antioxidant defense in human gastrointestinal diseases.
Patlevič P; Vašková J; Švorc P; Vaško L; Švorc P
Integr Med Res; 2016 Dec; 5(4):250-258. PubMed ID: 28462126
[TBL] [Abstract][Full Text] [Related]
11. Respiratory Burst Enzymes, Pro-Oxidants and Antioxidants Status in Bangladeshi Population with β-Thalassemia Major.
Hossain MF; Ismail M; Tanu AR; Shekhar HU
N Am J Med Sci; 2015 Jun; 7(6):253-8. PubMed ID: 26199921
[TBL] [Abstract][Full Text] [Related]
12. Free radicals and antioxidant status in chronic osteomyelitis patients: a case control study.
Jyoti A; Singh S; Mukhopadhyay B; Gavel R; Mishra SP
J Clin Diagn Res; 2015 Apr; 9(4):BC08-10. PubMed ID: 26046017
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress and Inflammation Levels in a Population of Eastern European Naïve Versus Treated Psoriasis Patients.
Cozma EC; Găman MA; Orzan O; Hamed KV; Voiculescu VM; Găman AM
Cureus; 2023 Nov; 15(11):e48177. PubMed ID: 38046733
[TBL] [Abstract][Full Text] [Related]
14. Intravascular hemolysis and the pathophysiology of sickle cell disease.
Kato GJ; Steinberg MH; Gladwin MT
J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in sickle cell disease.
Rees DC; Gibson JS
Br J Haematol; 2012 Feb; 156(4):433-45. PubMed ID: 22122125
[TBL] [Abstract][Full Text] [Related]
16. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.
Schaer DJ; Buehler PW; Alayash AI; Belcher JD; Vercellotti GM
Blood; 2013 Feb; 121(8):1276-84. PubMed ID: 23264591
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant supplementation for sickle cell disease.
Bolarinwa AB; Oduwole O; Okebe J; Ogbenna AA; Otokiti OE; Olatinwo AT
Cochrane Database Syst Rev; 2024 May; 5(5):CD013590. PubMed ID: 38775255
[TBL] [Abstract][Full Text] [Related]
18. Brucine Entrapped Titanium Oxide Nanoparticle for Anticancer Treatment: An
Almuqbil RM
Adv Pharmacol Pharm Sci; 2024; 2024():4646855. PubMed ID: 38529192
[No Abstract] [Full Text] [Related]
19. A Population Pharmacokinetic Analysis of L-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects.
Sadaf A; Dong M; Pfeiffer A; Latham T; Kalfa T; Vinks AA; Ware RE; Quinn CT
Clin Pharmacokinet; 2024 Mar; 63(3):357-365. PubMed ID: 38401036
[TBL] [Abstract][Full Text] [Related]
20. In vitro delayed response to dihydroartemisinin of malaria parasites infecting sickle cell erythocytes.
Gnondjui AA; Toure OA; Ako BA; Koui TS; Assohoun SE; Gbessi EA; N'Guessan LT; Tuo K; Beourou S; Assi SB; Yapo FA; Sanogo I; Jambou R
Malar J; 2024 Jan; 23(1):9. PubMed ID: 38178227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
